| Pharmaceutical Information |
| Drug Name |
Cefuroxime sodium |
| Drug ID |
BADD_D00409 |
| Description |
Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, gonorrhea, and haemophilus. |
| Indications and Usage |
For the treatment of many different types of bacterial infections such as bronchitis, sinusitis, tonsillitis, ear infections, skin infections, gonorrhea, and urinary tract infections. |
| Marketing Status |
approved |
| ATC Code |
S01AA27; J01DC02 |
| DrugBank ID |
DB01112
|
| KEGG ID |
D00915
|
| MeSH ID |
D002444
|
| PubChem ID |
23670318
|
| TTD Drug ID |
D0Y2IE
|
| NDC Product Code |
25021-183; 52946-0905; 25021-118; 25021-182; 25021-119 |
| UNII |
R8A7M9MY61
|
| Synonyms |
Cefuroxime | Cephuroxime | Zinacef | Ketocef |
|
| Chemical Information |
| Molecular Formula |
C16H15N4NaO8S |
| CAS Registry Number |
56238-63-2 |
| SMILES |
CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-].[Na+] |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
